344 related articles for article (PubMed ID: 32273506)
1. Cancer neoantigen prioritization through sensitive and reliable proteogenomics analysis.
Wen B; Li K; Zhang Y; Zhang B
Nat Commun; 2020 Apr; 11(1):1759. PubMed ID: 32273506
[TBL] [Abstract][Full Text] [Related]
2. ProGeo-neo: a customized proteogenomic workflow for neoantigen prediction and selection.
Li Y; Wang G; Tan X; Ouyang J; Zhang M; Song X; Liu Q; Leng Q; Chen L; Xie L
BMC Med Genomics; 2020 Apr; 13(Suppl 5):52. PubMed ID: 32241270
[TBL] [Abstract][Full Text] [Related]
3. Proteogenomics meets cancer immunology: mass spectrometric discovery and analysis of neoantigens.
Polyakova A; Kuznetsova K; Moshkovskii S
Expert Rev Proteomics; 2015; 12(5):533-41. PubMed ID: 26175083
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of peptides from non-coding genes in cancer proteomics datasets suggests potential tumor neoantigens.
Xiang R; Ma L; Yang M; Zheng Z; Chen X; Jia F; Xie F; Zhou Y; Li F; Wu K; Zhu Y
Commun Biol; 2021 Apr; 4(1):496. PubMed ID: 33888849
[TBL] [Abstract][Full Text] [Related]
5. An integrative proteogenomics approach reveals peptides encoded by annotated lincRNA in the mouse kidney inner medulla.
Flower CT; Chen L; Jung HJ; Raghuram V; Knepper MA; Yang CR
Physiol Genomics; 2020 Oct; 52(10):485-491. PubMed ID: 32866085
[TBL] [Abstract][Full Text] [Related]
6. A proteogenomic approach to target neoantigens in solid tumors.
Verma A; Halder A; Marathe S; Purwar R; Srivastava S
Expert Rev Proteomics; 2020; 17(11-12):797-812. PubMed ID: 33491499
[TBL] [Abstract][Full Text] [Related]
7. pVACtools: A Computational Toolkit to Identify and Visualize Cancer Neoantigens.
Hundal J; Kiwala S; McMichael J; Miller CA; Xia H; Wollam AT; Liu CJ; Zhao S; Feng YY; Graubert AP; Wollam AZ; Neichin J; Neveau M; Walker J; Gillanders WE; Mardis ER; Griffith OL; Griffith M
Cancer Immunol Res; 2020 Mar; 8(3):409-420. PubMed ID: 31907209
[TBL] [Abstract][Full Text] [Related]
8. Application of mass spectrometry-based MHC immunopeptidome profiling in neoantigen identification for tumor immunotherapy.
Zhang X; Qi Y; Zhang Q; Liu W
Biomed Pharmacother; 2019 Dec; 120():109542. PubMed ID: 31629254
[TBL] [Abstract][Full Text] [Related]
9. Best practices for bioinformatic characterization of neoantigens for clinical utility.
Richters MM; Xia H; Campbell KM; Gillanders WE; Griffith OL; Griffith M
Genome Med; 2019 Aug; 11(1):56. PubMed ID: 31462330
[TBL] [Abstract][Full Text] [Related]
10. A tool for integrating genetic and mass spectrometry-based peptide data: Proteogenomics Viewer: PV: A genome browser-like tool, which includes MS data visualization and peptide identification parameters.
Kroll JE; da Silva VL; de Souza SJ; de Souza GA
Bioessays; 2017 Jul; 39(7):. PubMed ID: 28582591
[TBL] [Abstract][Full Text] [Related]
11. Comparative Proteome Profiling and Mutant Protein Identification in Metastatic Prostate Cancer Cells by Quantitative Mass Spectrometry-based Proteogenomics.
Kwon OK; Ha YS; Lee JN; Kim S; Lee H; Chun SY; Kwon TG; Lee S
Cancer Genomics Proteomics; 2019; 16(4):273-286. PubMed ID: 31243108
[TBL] [Abstract][Full Text] [Related]
12. Linking cancer genome to proteome: NCI's investment into proteogenomics.
Rivers RC; Kinsinger C; Boja ES; Hiltke T; Mesri M; Rodriguez H
Proteomics; 2014 Dec; 14(23-24):2633-6. PubMed ID: 25187343
[TBL] [Abstract][Full Text] [Related]
13. PGNneo: A Proteogenomics-Based Neoantigen Prediction Pipeline in Noncoding Regions.
Tan X; Xu L; Jian X; Ouyang J; Hu B; Yang X; Wang T; Xie L
Cells; 2023 Mar; 12(5):. PubMed ID: 36899918
[TBL] [Abstract][Full Text] [Related]
14. Onco-proteogenomics: cancer proteomics joins forces with genomics.
Alfaro JA; Sinha A; Kislinger T; Boutros PC
Nat Methods; 2014 Nov; 11(11):1107-13. PubMed ID: 25357240
[TBL] [Abstract][Full Text] [Related]
15. ProGeo-Neo v2.0: A One-Stop Software for Neoantigen Prediction and Filtering Based on the Proteogenomics Strategy.
Liu C; Zhang Y; Jian X; Tan X; Lu M; Ouyang J; Liu Z; Li Y; Xu L; Chen L; Lin Y; Xie L
Genes (Basel); 2022 Apr; 13(5):. PubMed ID: 35627168
[TBL] [Abstract][Full Text] [Related]
16. Proteogenomics of Malignant Melanoma Cell Lines: The Effect of Stringency of Exome Data Filtering on Variant Peptide Identification in Shotgun Proteomics.
Lobas AA; Pyatnitskiy MA; Chernobrovkin AL; Ilina IY; Karpov DS; Solovyeva EM; Kuznetsova KG; Ivanov MV; Lyssuk EY; Kliuchnikova AA; Voronko OE; Larin SS; Zubarev RA; Gorshkov MV; Moshkovskii SA
J Proteome Res; 2018 May; 17(5):1801-1811. PubMed ID: 29619825
[TBL] [Abstract][Full Text] [Related]
17. Discovery of coding regions in the human genome by integrated proteogenomics analysis workflow.
Zhu Y; Orre LM; Johansson HJ; Huss M; Boekel J; Vesterlund M; Fernandez-Woodbridge A; Branca RMM; Lehtiö J
Nat Commun; 2018 Mar; 9(1):903. PubMed ID: 29500430
[TBL] [Abstract][Full Text] [Related]
18. Proteogenomic Platform for Identification of Tumor Specific Antigens.
Faktor J; Hernychová L; Vojtěšek B; Hupp T
Klin Onkol; 2018; 31(Suppl 2):102-107. PubMed ID: 31023032
[TBL] [Abstract][Full Text] [Related]
19. Proteogenomic discovery of cancer antigens: Neoantigens and beyond.
Kanaseki T; Tokita S; Torigoe T
Pathol Int; 2019 Sep; 69(9):511-518. PubMed ID: 31397525
[TBL] [Abstract][Full Text] [Related]
20. Methods for Optimization of Protein Extraction and Proteogenomic Mapping in Sweet Potato.
Al-Mohanna T; Bokros NT; Ahsan N; Popescu GV; Popescu SC
Methods Mol Biol; 2020; 2139():309-324. PubMed ID: 32462596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
